(Q38529981)

3 September 2017

1 reference

title

Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome (English)

1 reference

congenital adrenal hyperplasia due to 21-hydroxylase deficiency

3 September 2017

0 references

0 references

Henrik Falhammar

1

0 references

Anna Nordenström

series ordinal

2

object named as

Anna Nordenström

1 reference

3 September 2017

17 June 2015

1 reference

3 September 2017

1 reference

3 September 2017

50

1 reference

3 September 2017

1

1 reference

3 September 2017

32-50

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-015-0656-0

3 September 2017

0 references

cites work

HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Extensive clinical experience: nonclassical 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

A 31-year-old woman with infertility and polycystic ovaries diagnosed with non-classic congenital adrenal hyperplasia due to a novel CYP21 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Elevated 17-hydroxyprogesterone serum values in male patients with acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Refractory acne and 21-hydroxylase deficiency in a selected group of female patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

An 88-year-old woman diagnosed with adrenal tumor and congenital adrenal hyperplasia: connection or coincidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994-2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

High carrier frequency of 21-hydroxylase deficiency in Cyprus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Molecular genetics of 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Clinical outcomes in the management of congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Monitoring of therapy in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

24-hour blood pressure profiles in children with congenital adrenal hyperplasia on two different hydrocortisone treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Insulin sensitivity and body composition in children with classical and nonclassical congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Effect of four different oral contraceptives on various sex hormones and serum-binding globulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

The effect of simvastatin treatment on plasma steroid levels in females with non-classic congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

High prevalence of reduced fecundity in men with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Adult Height and Fertility in Men with Congenital Virilizing Adrenal Hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Quality of life in 70 women with disorders of sex development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Glucocorticoid-induced osteoporosis: pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Fractures and bone mineral density in adult women with 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Bone density in young patients with congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Height, bone mineral density and bone markers in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Mortality in patients with congenital adrenal hyperplasia: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Obesity in 21-hydroxylase deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Metabolic disorders in newly diagnosed young adult female patients with simple virilizing 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Adult patients with congenital adrenal hyperplasia have elevated blood pressure but otherwise a normal cardiovascular risk profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia--a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Observation of hypertension in children with 21-hydroxylase deficiency: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Adolescents with congenital adrenal hyperplasia because of 21-hydroxylase deficiency have vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Heart rate and cardiovascular mortality: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Malignancy associated with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Testicular adrenal rest tumours in boys, adolescents and adult men with congenital adrenal hyperplasia may be associated with the CYP21A2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Testis sparing surgery for steroid unresponsive testicular tumors of the congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Common genetic variants of the human steroid 21-hydroxylase gene (CYP21A2) are related to differences in circulating hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

A 68-year-old phenotypically male patient with 21-hydroxylase deficiency and concomitant adrenocortical neoplasm producing testosterone and cortisol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

A case of androgen-secreting adrenal carcinoma with non-classical congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Voice characteristics in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Voice problems due to virilization in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

21-Hydroxylase–deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Type of Mutation and Surgical Procedure Affect Long-Term Quality of Life for Women with Congenital Adrenal Hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0656-0

Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications

21 January 2018

1 reference

12 December 2020

Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates

1 reference

12 December 2020

Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia

1 reference

12 December 2020

A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma

1 reference

12 December 2020

A Feminizing Adrenocortical Carcinoma in the Context of a Late Onset 21-Hydroxylase Deficiency

1 reference

12 December 2020

1 reference

12 December 2020

Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus

1 reference

12 December 2020

Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate

1 reference

12 December 2020

Nonclassical congenital adrenal hyperplasia: targets of treatment and transition

1 reference

12 December 2020

Testicular adrenal rest tumours in congenital adrenal hyperplasia

1 reference

12 December 2020

TESTICULAR HILAR NODULES IN ADRENOGENITAL SYNDROME. THE NATURE OF THE NODULES

1 reference

12 December 2020

Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency.

1 reference

12 December 2020

High frequency of nonclassical steroid 21-hydroxylase deficiency

1 reference

12 December 2020

Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction

1 reference

12 December 2020

Sex steroids and insulin resistance

1 reference

12 December 2020

Neonatal screening for congenital adrenal hyperplasia

1 reference

12 December 2020

Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency

1 reference

12 December 2020

Testicular adrenal rest tissue in congenital adrenal hyperplasia: comparison of MR imaging and sonographic findings

1 reference

12 December 2020

The prevalence of testicular adrenal rest tumors and associated factors in postpubertal patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency

1 reference

12 December 2020

Absence of exercise-induced leptin suppression associated with insufficient epinephrine reserve in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia

1 reference

12 December 2020

An update on the frequency of nonclassic deficiency of adrenal 21-hydroxylase in the Yugoslav population

1 reference

12 December 2020

Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity

1 reference

12 December 2020

Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency

1 reference

12 December 2020

Non-classic congenital adrenal hyperplasia

1 reference

12 December 2020

A study of 34 cases of adrenal incidentaloma

1 reference

12 December 2020

Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency

1 reference

12 December 2020

Hormonally induced transformation of adrenal into myeloid tissue

1 reference

12 December 2020

Lipid profile in congenital adrenal hyperplasia

1 reference

12 December 2020

Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency

1 reference

12 December 2020

Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood

1 reference

12 December 2020

Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population

1 reference

12 December 2020

Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study

1 reference

12 December 2020

Long term outcome in adult males with classic congenital adrenal hyperplasia

1 reference

12 December 2020

Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy

1 reference

12 December 2020

Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia.

1 reference

12 December 2020

Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency

1 reference

12 December 2020

Molecular characterization of testicular adrenal rest tumors in congenital adrenal hyperplasia: lesions with both adrenocortical and Leydig cell features

1 reference

12 December 2020

Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population

1 reference

12 December 2020

Blood pressure in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency

1 reference

12 December 2020

The frequency of 21-alpha hydroxylase enzyme deficiency and related sex hormones in Iraqi healthy male subjects versus patients with acne vulgaris.

1 reference

12 December 2020

Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study

1 reference

12 December 2020

Inadequate cortisol response to the tetracosactide (Synacthen®) test in non-classic congenital adrenal hyperplasia: an exception to the rule?

1 reference

12 December 2020

Giant bilateral myelolipomas in a man with congenital adrenal hyperplasia

1 reference

12 December 2020

Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency

1 reference

12 December 2020

Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue

1 reference

12 December 2020

Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

1 reference

12 December 2020

The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life

1 reference

12 December 2020

[Prevalence of frequent recessive diseases in the Spanish population through DNA analyses on samples from the neonatal screening]

1 reference

12 December 2020

Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life

1 reference

12 December 2020

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Increased prevalence of testicular adrenal rest tumours during adolescence in congenital adrenal hyperplasia

1 reference

12 December 2020

High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency

1 reference

12 December 2020

Testicular adrenal rest tissue in congenital adrenal hyperplasia: findings at Gray-scale and color Doppler US

1 reference

12 December 2020

[Clinically late virilism with excretion of pregnanetriol and insufficiency of cortisol production]

1 reference

12 December 2020

The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.

1 reference

12 December 2020

Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study

1 reference

12 December 2020

Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Non-classic congenital adrenal hyperplasia due to 21-hydoxylase deficiency as a cause of infertility and miscarriages.

1 reference

12 December 2020

Testis sparing surgery for steroid unresponsive testicular tumors of the adrenogenital syndrome

1 reference

12 December 2020

Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation

1 reference

12 December 2020

Adrenocortical carcinoma associated with adrenogenital syndrome in a child

1 reference

12 December 2020

Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy

1 reference

12 December 2020

CLINICAL OUTCOMES IN ADRENAL INCIDENTALOMA: EXPERIENCE FROM ONE CENTER.

1 reference

12 December 2020

Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glycemic control during prolonged moderate-intensity exercise

1 reference

12 December 2020

Bone mineral density and body composition in congenital adrenal hyperplasia

1 reference

12 December 2020

High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia

1 reference

12 December 2020

Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway

1 reference

12 December 2020

10.1007/S12020-015-0656-0

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

26082286